Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate Cancer

NCT00137436 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Neoplasms

Interventions

DRUG: Docetaxel
DRUG: Prednisone
DRUG: SU011248

Sponsor

Pfizer